|
[1]
|
李雷, 孙怡咪, 刘刚. 冠脉CTA定量参数与冠心病患者疾病进展和预后的关系[J]. 海南医学, 2022, 33(20): 2672-2675.
|
|
[2]
|
Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-3021.
|
|
[3]
|
Safiri, S., Karamzad, N., Singh, K., Carson-Chahhoud, K., Adams, C., Nejadghaderi, S.A., et al. (2021) Burden of Ischemic Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. European Journal of Preventive Cardiology, 29, 420-431. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
刘明波, 何新叶, 杨晓红, 王增武. 《中国心血管健康与疾病报告2024》要点解读[J]. 心肺血管病杂志, 2025, 44(9): 899-917.
|
|
[5]
|
Wang, X., Gao, M., Zhou, S., Wang, J., Liu, F., Tian, F., et al. (2017) Trend in Young Coronary Artery Disease in China from 2010 to 2014: A Retrospective Study of Young Patients ≤ 45. BMC Cardiovascular Disorders, 17, Article No. 18. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Burgess, S.N. (2022) Understudied, Under-Recognized, Underdiagnosed, and Undertreated: Sex-Based Disparities in Cardiovascular Medicine. Circulation: Cardiovascular Interventions, 15, e011714. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wenger, N.K., Lloyd-Jones, D.M., Elkind, M.S.V., Fonarow, G.C., Warner, J.J., Alger, H.M., et al. (2022) Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory from the American Heart Association. Circulation, 145, e1059-e1071. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
查志敏, 刘欢, 王向明, 李秋爽, 郭妍. 心脏瓣膜钙化对老年冠心病病人预后的影响[J]. 实用老年医学, 2024, 38(3): 245-250.
|
|
[9]
|
Saran, N., Greason, K.L., Schaff, H.V., Cicek, S.M., Daly, R.C., Maltais, S., et al. (2019) Does Mitral Valve Calcium in Patients Undergoing Mitral Valve Replacement Portend Worse Survival? The Annals of Thoracic Surgery, 107, 444-452. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
陈焱, 徐清, 周庆志, 等. 残余胆固醇对血压正常高值冠心病患者发生MACCE的临床预后价值[J]. 中国动脉硬化杂志, 2022, 30(10): 878-883.
|
|
[11]
|
Li, X., Li, Z. and Wu, N. (2025) Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine, 26, Article No. 25985. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Riis, J., Nordestgaard, B.G. and Afzal, S. (2025) High Remnant Cholesterol and Atherosclerotic Cardiovascular Disease in Healthy Women and Men Aged 70-100. European Journal of Preventive Cardiology, 32, 1169-1177. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhang, Y., Song, K., Bi, S., Li, M. and Yao, Z. (2024) Higher Remnant Cholesterol Increases the Risk of Coronary Heart Disease and Diabetes in Postmenopausal Women. Frontiers in Endocrinology, 15, Article ID: 1475933. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
文玉鑫. 老年退行性心脏瓣膜病临床分析[D]: [硕士学位论文]. 南宁: 广西医科大学, 2021.
|
|
[15]
|
Aronow, W.S., Ahn, C. and Kronzon, I. (1999) Association of Mitral Annular Calcium and of Aortic Cuspal Calcium with Coronary Artery Disease in Older Patients. The American Journal of Cardiology, 84, 1084-1085. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Jiang, C., Yao, D., Shen, Q., Tian, R., Fan, L., Zheng, Q., et al. (2025) Oxidized LDL-Induced FOXS1 Mediates Cholesterol Transport Dysfunction and Inflammasome Activation to Drive Aortic Valve Calcification. Cardiovascular Research, 121, 1941-1955. [Google Scholar] [CrossRef]
|
|
[17]
|
Lerman, D.A., Prasad, S. and Alotti, N. (2015) Calcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic Approaches. European Cardiology Review, 10, 108-112. [Google Scholar] [CrossRef] [PubMed]
|